|
Cerebrovascular Disease
Citations 31-40 of 236 total displayed.
|
Past content
(since Feb 1998):
|
- Letters
Risk of Major Adverse Cardiovascular Events With Inhaled Anticholinergics in Patients With Chronic Obstructive Pulmonary Disease
- Steven Kesten; Inge Leimer; Michele Jara
JAMA 2009; 301: 1224.
[Extract]
[Full text]
[PDF]
- Letters
Risk of Major Adverse Cardiovascular Events With Inhaled Anticholinergics in Patients With Chronic Obstructive Pulmonary Disease—Reply
- Sonal Singh; Yoon K. Loke; Curt D. Furberg
JAMA 2009; 301: 1225-1226.
[Extract]
[Full text]
[PDF]
- Corrections
Incorrect Data in: Inhaled Anticholinergics and Risk of Major Adverse Cardiovascular Events in Patients With Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-analysis
-
JAMA 2009; 301: 1227-1230.
[Full text]
[PDF]
- Corrections
Incomplete Financial Disclosures in: Escitalopram and Problem-Solving Therapy for Prevention of Poststroke Depression: A Randomized Controlled Trial
-
JAMA 2009; 301: 1024-d.
[Full text]
[PDF]
- Letters
Mild Cognitive Impairment, Carotid Disease, and Revascularization
- Allyson Zazulia
JAMA 2009; 301: 829-a.
[Extract]
[Full text]
[PDF]
- Letters
Mild Cognitive Impairment, Carotid Disease, and Revascularization—Reply
- James M. Ellison
JAMA 2009; 301: 830-a.
[Extract]
[Full text]
[PDF]
- Book and Media Reviews
Le Scaphandre et le Papillon (The Diving Bell and the Butterfly)
- Numbere Numbere
JAMA 2008; 300: 2924-2925.
[Extract]
[Full text]
[PDF]
- Grand Rounds
Evolution of Novel Small-Molecule Therapeutics Targeting Sickle Cell Vasculopathy
- Gregory J. Kato; Mark T. Gladwin
JAMA 2008; 300: 2638-2646.
[Abstract]
[Full text]
[PDF]
- JAMA Patient Page
Sickle Cell Vasculopathy
- Carolyn J. Hildreth; Alison E. Burke; Richard M. Glass
JAMA 2008; 300: 2690.
[Extract]
[Full text]
[PDF]
[ Spanish PDF ]
- JAMA Classics
Framingham Study Insights on the Hazards of Elevated Blood Pressure
- William B. Kannel; Phillip A. Wolf
JAMA 2008; 300: 2545-2547.
[Extract]
[Full text]
[PDF]
[ Original Article ]
|
|
